Encore Vision

Encore Vision is a developer of therapeutic solutions and technologies for the treatment of presbyopia.

Encore Vision is developing a “first in class” technology for the treatment of presbyopia. The Company has been well-financed and mentored by leading ophthalmologists and optometrists during its incubation phase. Encore Vision has achieved significant progress in developing extensive Intellectual Property protection. Encore Vision’s technology is covered by a robust and growing patent portfolio which includes one issued broad-based US patent, notice of allowance on a second U.S. patent and more than 40 Pending US and Foreign patent applications and provisional filings, including composition of matter applications for its proprietary formulations. The Company has completed in-vivo proof of concept in an animal model for presbyopia and has begun development activities leading to clinical studies in man.